BioSpace News Archive

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CE-IVD-marked COVID-19 test

Neuronetics, Inc. announced that the company will be added to the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.

Cipher Pharmaceuticals Inc. today announced the voting results for the election of directors at its Annual Meeting of Shareholders held earlier today.

Doximity, Inc. (“Doximity”) (NYSE: DOCS) today announced the pricing of its initial public offering of 23,300,000 shares of its Class A common stock at a price to the public of $26.00 per share.

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces today it has completed Cohort 3 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease

Certara today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of Certara’s Simcyp™ and Phoenix™ biosimulation software.

BioArctic AB’s today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for lecanemab (BAN2401), an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease.

Monte Rosa Therapeutics, Inc. today announced the pricing of its initial public offering of 11,700,000 shares of common stock at a public offering price of $19.00 per share.